Generation of neutralizing monoclonal antibodies against Enterovirus 71 using synthetic peptides

Biochemical and Biophysical Research Communications

Volumn 390, Issue 4, 2009, Pages 1126-1128

  Li, Xiuling ^a   Mao, Chunming ^b   Ma, Shujun ^b   Wang, Xiaoqing ^b   Sun, Zhe ^b   Yi, Yao ^c   Guo, Minzhuo ^c   Shen, Xinliang ^a   Sun, Le ^b   Bi, Shengli ^c  

^a Beijing Tiantan Biological Products Co Ltd   (China)

^b AbMax   (China)

^c CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

Author keywords

Clone 22A12; Enterovirus 71 (EV71); Monoclonal antibody; Neutralizing

Indexed keywords

AMINO ACID DERIVATIVE; ANTIBODY; EV71 PEPTIDE MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY; SP55 PROTEIN; SP70 PROTEIN; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY SPECIFICITY; ARTICLE; ASSAY; CONTROLLED STUDY; ENTEROVIRUS 71; ENTEROVIRUS INFECTION; IMMUNIZATION; IMMUNOCYTOCHEMISTRY; IN VITRO STUDY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; WESTERN BLOTTING;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; COXSACKIEVIRUS INFECTIONS; ENTEROVIRUS A, HUMAN; HAND, FOOT AND MOUTH DISEASE; HUMANS; MICE; NEUTRALIZATION TESTS; PEPTIDES; VIRAL VACCINES;

HUMAN ENTEROVIRUS 71; MUS;

EID: 70549097113     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.09.103     Document Type: Article

References (11)

1. Brown A.B., Oberste M.S., Alexander Jr. J.P., Margery L.K., and Mark A.P. Molecular epidemiology and evolution of Enterovirus 71 strains isolated from 1970 to 1998. J. Virol. 73 (1999) 9969-9975
2. Hagiwara A., Tagaya I., and Yoneyama T. Epidemic of hand, foot and mouth disease associated with Enterovirus 71 infection. Intervirology 9 (1978) 60-63
3. McMinn P.C. An overview of the evolution of Enterovirus 71 and its clinical and public health significance. FEMS Microbiol. Rev. 26 (2002) 91-107
4. Ho M., Chen E.R., Hsu K.H., Twu S.J., Chen K.T., Tsai S.F., Wang J.R., and Shih S.R. An epidemic of enterovirus infection in Taiwan. Taiwan Enterovirus Epidemic Working Group. N. Engl. J. Med. 341 (1999) 929-935
5. Liu C.C., Tseng H.W., Wang S.M., Wang J.R., and Su I.J. An outbreak of Enterovirus 71 infection in Taiwan, 1998; epidemiologic and clinical manifestations. J. Clin. Virol. 17 (2000) 23-30
6. Chan K.P., Goh K.T., Chong C.Y., Teo E.S., Lau G., and Ling A.E. Epidemic hand, foot and mouth disease caused by human Enterovirus 71. Singapore Emerg. Infect. Dis. 9 (2003) 78-85
7. W.B. Xu, Virus surveillance on HFMD in China, in: Beijing International Symposium on HFMD, 2009.
8. Infectious Case Report for June 2009 by Ministry of Public Health of China.
9. The IMpact RSV Study Group. Palivizumab a humanized respiratory syncytial virus monoclonal antibody reduces hospitalization from respiratory syncytial virus infection in high-risk infants. Pediatrics 102 (1998) 531-537
10. Lal S.K., Kumar P., Yeo W.M., Kar-Roy A., and Chow V.T. The VP1 protein of human Enterovirus 71 self-associates via an interaction domain spanning amino acids 66-297. J. Med. Virol. 78 (2006) 582-590
11. Guang D.M., Foo W., Alonso S., Phoon M.C., Ramachandran N.P., Chow V.T.K., and Poh C.L. Identification of neutralizing linear epitopes from the VP1 capsid protein of Enterovirus 71 using synthetic peptides. Virus Res. 125 (2007) 61-68